Literature DB >> 15568014

Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation.

Ami Citri1, Judith Gan, Yaron Mosesson, Gyorgi Vereb, Janos Szollosi, Yosef Yarden.   

Abstract

ErbB-2/HER2 is an oncogenic tyrosine kinase that regulates a signalling network by forming ligand-induced heterodimers with several growth factor receptors of the ErbB family. Hsp90 and co-chaperones regulate degradation of ErbB-2 but not other ErbB members. Here, we report that the role of Hsp90 in modulating the ErbB network extends beyond regulation of protein stability. The capacity of ErbB-2 to recruit ligand-bound receptors into active heterodimers is limited by Hsp90, which is dissociated from ErbB-2 following ligand-induced heterodimerization. We show that Hsp90 binds a specific loop within the kinase domain of ErbB-2, thereby restraining heterodimer formation and catalytic function. These results define a role for Hsp90 as a molecular switch regulating the ErbB signalling network by limiting formation of ErbB-2-centred receptor complexes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568014      PMCID: PMC1299195          DOI: 10.1038/sj.embor.7400300

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  15 in total

Review 1.  The conformational plasticity of protein kinases.

Authors:  Morgan Huse; John Kuriyan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

Review 2.  Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery.

Authors:  William B Pratt; David O Toft
Journal:  Exp Biol Med (Maywood)       Date:  2003-02

Review 3.  Mechanism of action of erbB tyrosine kinase inhibitors.

Authors:  David W Fry
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

4.  Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37.

Authors:  Thomas Prince; Robert L Matts
Journal:  J Biol Chem       Date:  2004-07-17       Impact factor: 5.157

5.  The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR.

Authors:  O Donzé; T Abbas-Terki; D Picard
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

6.  Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy.

Authors:  Ami Citri; Iris Alroy; Sara Lavi; Chanan Rubin; Wanping Xu; Nicolas Grammatikakis; Cam Patterson; Len Neckers; David W Fry; Yosef Yarden
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

Review 7.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

8.  Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1.

Authors:  J Zou; Y Guo; T Guettouche; D F Smith; R Voellmy
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

9.  Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation.

Authors:  Oleg Tikhomirov; Graham Carpenter
Journal:  Cancer Res       Date:  2003-01-01       Impact factor: 12.701

10.  Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases.

Authors:  L Sepp-Lorenzino; Z Ma; D E Lebwohl; A Vinitsky; N Rosen
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

View more
  59 in total

1.  Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives.

Authors:  Robert P Sellers; Leslie D Alexander; Victoria A Johnson; Chun-Chieh Lin; Jeremiah Savage; Ricardo Corral; Jason Moss; Tim S Slugocki; Erinprit K Singh; Melinda R Davis; Suchitra Ravula; Jamie E Spicer; Jenna L Oelrich; Andrea Thornquist; Chung-Mao Pan; Shelli R McAlpine
Journal:  Bioorg Med Chem       Date:  2010-07-22       Impact factor: 3.641

2.  Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.

Authors:  Andrew J Shih; Shannon E Telesco; Sung-Hee Choi; Mark A Lemmon; Ravi Radhakrishnan
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

3.  Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation.

Authors:  Fumitaka Koga; Wanping Xu; Tatiana S Karpova; James G McNally; Roland Baron; Len Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-14       Impact factor: 11.205

4.  Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.

Authors:  Wanping Xu; Xitong Yuan; Kristin Beebe; Zhexin Xiang; Len Neckers
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

Review 5.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 6.  The Hsp90 chaperone machinery regulates signaling by modulating ligand binding clefts.

Authors:  William B Pratt; Yoshihiro Morishima; Yoichi Osawa
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

7.  The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells.

Authors:  Alexandra Canonici; Zulfiqar Qadir; Neil T Conlon; Denis M Collins; Neil A O'Brien; Naomi Walsh; Alex J Eustace; Norma O'Donovan; John Crown
Journal:  Invest New Drugs       Date:  2018-02-02       Impact factor: 3.850

8.  Geldanamycin selectively targets the nascent form of ERBB3 for degradation.

Authors:  Candice S Gerbin; Ralf Landgraf
Journal:  Cell Stress Chaperones       Date:  2010-01-19       Impact factor: 3.667

9.  Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells.

Authors:  Chun Hei Antonio Cheung; Huang-Hui Chen; Li-Ting Cheng; Kevin W Lyu; Jagat R Kanwar; Jang-Yang Chang
Journal:  Mol Cancer       Date:  2010-04-15       Impact factor: 27.401

10.  Structure-function analysis of nucleolin and ErbB receptors interactions.

Authors:  Keren Farin; Ayelet Di Segni; Adam Mor; Ronit Pinkas-Kramarski
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.